According to law enforcement and health officials, "bath salts" are powerful synthetic stimulants, designed to be comparable in effect to cocaine or methamphetamine, carrying similar risks. Unlike cocaine or methamphetamine, these stimulants are currently legal in many parts of the United States and available at a low cost in many convenience stores and head shops.
According to law enforcement and health officials, "bath salts" are powerful synthetic stimulants, designed to be comparable in effect to cocaine or methamphetamine, carrying similar risks. Unlike cocaine or methamphetamine, these stimulants are currently legal in many parts of the United States and available at a low cost in many convenience stores and head shops.
Recognition of the potential risks has prompted many regions to ban the sale of bath salts, leading to the need for analytical methods to meet the challenges associated with regulation enforcement. In addition, there exists a need for fast and reliable methods for use in health care facilities.
Figure 1 shows the structures and selected physiochemical properties of two bath salt components. These compounds are representative of a class of polar, basic molecules. Such analytes are often difficult to retain and separate using standard reversed-phase chromatography. Several of the analytes exhibit similar solubility properties as indicated by the comparable predicted LogD values. Several compounds also show almost equivalent ionization constants as well. These efforts, therefore, focused on the use of HILIC chromatographic techniques to obtain efficient retention and selectivity.
Figure 1: Structures and physiochemical properties of two representative bath salts (1,2).
Figure 2 shows a highly efficient LC–MS separation of six chosen analytes using Ascentis® Express HILIC. The HILIC phase exhibits partition and ion-exchange characteristics, making it highly suitable for separation of polar, weak bases. Attempts at obtaining equivalent separation using conventional C18 or alternative reversed-phase chemistries have been unsuccessful to date. In addition, of the HILIC phases explored, only Ascentis Express HILIC provided baseline resolution of all six analytes.
Figure 2: Analysis of illicit bath salts on Ascentis Express HILIC. System: Agilent 1200SL Rapid Resolution, 6210 TOF, Column: Ascentis Express HILIC, 5 cm à 2.1 mm I.D., 2.7 µm (53934-U), Mobile Phase: 5 mM ammonium formate (5:95 water:acetonitrile), Flow Rate: 0.6 mL/min., Temp.: 35 °C, System Pressure: 88 bar, Inj.: 1 µL, MS Detection: ESI+, 100â1000 m/z, Peaks: 1. MDPV, 2. Butylone, 3. Ethylone, 4. Mephedrone, 5. Methylone, 6. Methedrone.
HILIC chromatography involves the partition of polar analytes from a relatively nonpolar mobile phase into a semistagnant aqueous layer adsorbed onto the surface of a polar stationary phase. In addition, ion-exchange and other polar interactions are likely to occur. For these polar bases, there are multiple mechanisms of interaction to help distinguish them during a chromatographic run. Ascentis Express HILIC columns proved to be the best choice for baseline resolution of these six potentially dangerous materials sold as bath salts. Further experimentation is planned to apply this separation to a variety of biological matrices.
(1) LogD(7.4) and pKa values estimated using ACD/Labs PhysChem software, version 12.
(2) Standard materials kindly provided by Cerilliant Corporation (Round Rock, Texas).
Ascentis is a registered trademark of Sigma-Aldrich Co. LLC.
Supelco/Sigma Aldrich
595 North Harrison Road, Bellefonte, PA 16823
tel. (800) 359-3041, fax (800) 359-3044
Website: www.sigma-aldrich.com
The Benefits of Custom Bonded Silica
April 1st 2025Not all chromatography resins are created equal. Off-the-shelf chromatography resins might not always meet the rigorous purification requirements of biopharmaceutical manufacturing. Custom bonded silica from Grace can address a wide range of separation challenges, leading to real performance improvements. Discover more about the latest innovations in chromatography silica from Grace, including VYDAC® and DAVISIL®.
5 Things to Consider When Selecting a Chromatography Silica
April 1st 2025Particularly in the pharmaceutical industry, drug purity isn’t just a goal – it’s essential for achieving safety, stability and efficacy. However, purification is easier said than done, especially with challenging molecules like DNA and RNA “oligonucleotides,” due in large part to their diversity and the range of impurities that can be generated during production. Enter DAVISIL® chromatographic silica, with a wide range of pore diameters and particle sizes to meet your specific application, performance and sustainability requirements. Before you choose the chromatography resin for your next purification application, take a look at these 5 considerations.
Automating Protein Purification: Efficiency, Yield, and Reproducibility
March 27th 2025Recent advancements in automated protein purification stress the importance of efficiency, scalability, and yield consistency. This eBook compares different purification platforms, highlighting their impact on downstream applications and demonstrating how automation enhances throughput and process control.
MilliporeSigma: Ultrapure Water for Sensitive LC-MS Analysis of Pesticides
March 25th 2025The aim of the study was to illustrate the efficiency of Milli-Q® water purification systems in eliminating pesticides from tap water, thereby producing and delivering reliable and consistent-quality ultrapure water suitable for pesticides analysis